Prognostic, predictive, and surrogate value of HER2 extracellular domain (ECD) for progression-free survival (PFS) in advanced breast cancer treated with lapatinib (lap): A meta-analysis.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Health and Medical Research Council, Macquarie University, Hospital of Prato, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Virginia Commonwealth University, University of Edinburgh, USC Norris Comprehensive Cancer Center, GlaxoSmithKline (United States), Peter MacCallum Cancer Centre, Western Sydney University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589711376